EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AMPK/SIRT1/PGC‐1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy

Junyang Chen, Boya Liu, Xinlei Yao, Xiaoming Yang, Jiacheng Sun, Jia Yi, Fei Xue, Jitai Zhang, Yuntian Shen iD, Bingqian Chen, Hualin Sun iD

CNS Neuroscience & Therapeutics · 2025-11 · 31 (11)

DOI: 10.1111/cns.70657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 21.11.2025. Verfasst von Junyang Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Cente…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Sirtuin 1, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Signal Transduction. Die Arbeit wurde bisher 235-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Research Projects in Universities of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The AMPK/SIRT1/PGC‐1α pathway serves as a central regulator of cellular energy homeostasis, coordinating metabolic stress responses, epigenetic modifications, and transcriptional programs. Its dysfunction is implicated in the pathogenesis of a wide spectrum of complex modern diseases, spanning neurodegeneration, metabolic syndromes, and chronic inflammatory conditions. This review examines the pathway's role as an integrative hub and its potential as a therapeutic target.

Methods

We synthesize current mechanistic evidence from molecular, cellular, and preclinical studies to elucidate the pathway's operational logic and the consequences of its dysregulation. The analysis is structured around key disease paradigms—including Alzheimer's disease, Parkinson's disease, diabetes, cardiovascular injury, stroke, and chronic kidney disease—to dissect its tissue‐specific pathophysiological impacts.

Results

The AMPK/SIRT1/PGC‐1α axis operates through a core positive feedback loop: AMPK activation elevates NAD+, thereby activating SIRT1, which in turn deacetylates and activates PGC‐1α to drive mitochondrial biogenesis and function, further reinforcing SIRT1 activity. Disruption of this cascade manifests in disease‐specific mechanisms: promoting Aβ production via BACE1/γ‐secretase in Alzheimer's; impairing α‐synuclein clearance in Parkinson's; disrupting GLUT4 translocation and insulin signaling in diabetes; exacerbating oxidative damage and mitochondrial dysfunction in cardiovascular and neuronal injury; and accelerating fibrosis and sustained inflammation in renal and pulmonary diseases via NLRP3 and TGF‐β/Smad3 signaling.

Conclusions

The AMPK/SIRT1/PGC‐1α pathway represents a cornerstone target at the intersection of metabolism, aging, and disease. Current therapeutic strategies—including pharmacological activators (e.g., metformin, SRT1720), natural compounds (e.g., resveratrol), lifestyle interventions (e.g., exercise, caloric restriction), and emerging technologies (e.g., gene editing, exosomal miRNAs)—offer multidimensional avenues for intervention. Future research must prioritize elucidating tissue‐specific regulatory mechanisms, such as AMPK isoform diversity and PGC‐1α interactome dynamics, to enable precision therapeutics and successful clinical translation for a range of complex disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesSirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSignal TransductionDiseaseHumansHomeostasisEpigenesis, GeneticMitochondriaFeedback, PhysiologicalEnergy MetabolismAnimals

Substanzen

AMP-Activated Protein KinasesSirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province,…
  • Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu City, Changshu, Jiangsu Province, China.

ORCID-Profile: Yuntian Shen, Hualin Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Natural Science Research Projects in Universities of Jiangsu Province
  • Suzhou Science and Technology Development Program

Zitieren

APA

Chen, J., Liu, B., Yao, X., Yang, X., Sun, J., Yi, J., Xue, F., Zhang, J., Shen, Y., Chen, B., & Sun, H. (2025). AMPK/SIRT1/PGC‐1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy. CNS Neuroscience & Therapeutics, 31(11). https://doi.org/10.1111/cns.70657

Vancouver

Chen J, Liu B, Yao X, Yang X, Sun J, Yi J, et al. AMPK/SIRT1/PGC‐1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy. CNS Neuroscience & Therapeutics. 2025;31(11). doi:10.1111/cns.70657

BibTeX
@article{Chen2025,
  author = {Chen, Junyang and Liu, Boya and Yao, Xinlei and Yang, Xiaoming and Sun, Jiacheng and Yi, Jia and Xue, Fei and Zhang, Jitai and Shen, Yuntian and Chen, Bingqian and Sun, Hualin},
  title = {AMPK/SIRT1/PGC‐1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {11},
  doi = {10.1111/cns.70657}
}
Kostenlos starten →